pentobarbital decreases amounts of panobinostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Solid CYP3A4 inducers can lower panobinostat amounts by ~70% and bring about therapy failure.Caution is warranted for people with renal and hepatic impairment. Whilst the maker does not give certain dosage adjustment tips for r